Inagaki Yusuke, Fukuhara Shinichiro, Imamura Ryoichi, Kobayashi Yuki, Kuribayashi Sohei, Okada Koichi, Sekii Yosuke, Takezawa Kentaro, Kiuchi Hiroshi, Uemura Motohide, Kobayashi Hikaru, Nonomura Norio
Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
The Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Japan.
Andrology. 2021 Jan;9(1):376-383. doi: 10.1111/andr.12890. Epub 2020 Sep 9.
Varicocoele-induced male infertility potentially involves oxidative stress. Although varicocoelectomy is recommended for varicocoele patients presenting abnormal semen findings, no pharmacotherapeutic methods currently exist. We have recently developed a silicon-based agent that produces hydrogen by the reaction with water.
This study aimed to investigate the therapeutic effects of oral administration of a Si-based agent on varicocoele rat.
Twenty-one rats were divided into four groups: varicocoele + normal diet (n = 5), varicocoele + Si-based agent-supplemented diet (n = 6), sham + normal diet (n = 5), and sham + Si-based agent-supplemented diet (n = 5). All rats were euthanized four weeks after surgery.
The mean left epididymal sperm motility was 74.4% in the sham group, 72.3% in the sham + Si group, 57.6% in the varicocoele group, and 66.9% in the varicocoele + Si group. Epididymal sperm motility was significantly lower in the varicocoele group, but was significantly higher upon Si-based agent ingestion (P < .01). The mean left testicular weight, Johnsen's score, and left epididymal sperm concentration did not differ significantly between groups. The 8-OHdG concentration and DNA fragmentation rate were significantly increased in the varicocoele group, but were significantly decreased in the Si-based agent intake group (P < .01). Additionally, the IVF rate was significantly lower in the varicocoele group (26.3%) compared with the sham group (73.4%; P < .01), and was significantly higher in the varicocoele + Si group (51.8%) compared with the varicocoele group (P < .05), indicating that the Si-based agent improves IVF rates.
Oral intake of the silicon-based agent improves epididymal sperm motility and in vitro fertilization rates through hydrogen production and subsequent reduction of oxidative stress. Considering the lack of effective noninvasive methods, this Si-based agent is potentially applicable for treating varicocoele-induced abnormal semen parameters.
精索静脉曲张所致男性不育可能与氧化应激有关。尽管对于精液检查异常的精索静脉曲张患者推荐进行精索静脉结扎术,但目前尚无药物治疗方法。我们最近研发了一种通过与水反应产生氢气的硅基制剂。
本研究旨在探讨口服硅基制剂对精索静脉曲张大鼠的治疗效果。
将21只大鼠分为四组:精索静脉曲张+正常饮食组(n = 5)、精索静脉曲张+补充硅基制剂饮食组(n = 6)、假手术+正常饮食组(n = 5)以及假手术+补充硅基制剂饮食组(n = 5)。所有大鼠在手术后四周实施安乐死。
假手术组左侧附睾精子活力均值为74.4%,假手术+硅基制剂组为72.3%,精索静脉曲张组为57.6%,精索静脉曲张+硅基制剂组为66.9%。精索静脉曲张组附睾精子活力显著降低,但摄入硅基制剂后显著升高(P <.01)。各组间左侧睾丸平均重量、约翰森评分及左侧附睾精子浓度无显著差异。精索静脉曲张组8-羟基脱氧鸟苷浓度和DNA碎片化率显著升高,但硅基制剂摄入组显著降低(P <.01)。此外,精索静脉曲张组的体外受精率(26.3%)显著低于假手术组(73.4%;P <.01),而精索静脉曲张+硅基制剂组(51.8%)显著高于精索静脉曲张组(P <.05),表明硅基制剂可提高体外受精率。
口服硅基制剂通过产生氢气及随后减轻氧化应激,提高了附睾精子活力和体外受精率。鉴于缺乏有效的非侵入性方法,这种硅基制剂可能适用于治疗精索静脉曲张所致的精液参数异常。